NSEOptions to purchase securities1d ago · 17 Nov 2026, 05:34 pm
Options to purchase securities
Nephrocare Health Services Limited · NEPHROPLUS
✦ AI Summaryoptions_to_purchase_securities
Nephrocare Health Services Limited has informed the Exchange about the grant of an aggregate of 38,236 Employee Stock Options under the NephroPlus Employee Stock Option Scheme, 2026, to eligible employees.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nephrocare Health Services Limited has informed the Exchange about Options to purchase securities
Attachments (1)
📄pdf
Download →
NEPHROCARE1_17112026173441_20261117_Reg_30_ESOP_Grant_of_Options_clean_signed.pdf
View document text
November 17, 2026 Ref: NEPHROPLUS/SE/103
To To
BSE Limited National Stock Exchange of India Limited
P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E),
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 544647 Scrip Symbol: NEPHROPLUS
Through: BSE Listing Centre Through: NEAPS
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 – Grant of Employee Stock Options under NephroPlus Employee Stock Option
Scheme, 2026.
Dear Sir / Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III and other applicable provisions of
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing
Regulations”), we hereby inform you that the Nomination and Remuneration Committee (“NRC”) of
the Board of Directors of Nephrocare Health Services Limited (“the Company”), by way of a circular
resolution passed on November 17, 2026, has approved the grant of an aggregate of 38,236 (Thirty-
Eight Thousand Two Hundred and Thirty-Six only) Employee Stock Options (“Options”) under the
NephroPlus Employee Stock Option Scheme, 2026 (“ESOP 2026”) to eligible employees identified by
the NRC.
Each Option, upon vesting and exercise in accordance with the terms and conditions of ESOP 2026
and the respective Grant Letters, shall entitle the Option Grantee to acquire one fully paid-up equity
share of the Company having a face value of ₹2/- (Rupees Two only) each. The Options have been
granted at an Exercise Price of ₹513.60 (Rupees Five Hundred Thirteen and Sixty Paise only) per Option
and shall vest subject to fulfilment of the applicable vesting conditions, as specified in the respective
Grant Letters.
The relevant details with respect to the aforesaid grant, as required under the SEBI Listing Regulations
read with SEBI Master Circular Ref. No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January
30, 2026, are enclosed as Annexure I.
The aforesaid information is also being made available on the Company's website at
www.nephroplus.com
Yours faithfully,
For Nephrocare Health Services Limited
(Formerly Nephrocare Health Services Private Limited)
Kishore Kathri
Company Secretary and Head Legal
Membership No.: F9895
Annexure I
Details of grant of Employee Stock Options under the NephroPlus Employee Stock Option Scheme,
2026
Sr. Particulars Details
1 Brief details of Options The NRC has approved the grant of an aggregate of 38,236
granted (Thirty-Eight Thousand Two Hundred and Thirty-Six only)
Employee Stock Options (“Options”) under ESOP 2026 to eligible
employees of the Company. Each Option, upon vesting and
exercise, shall entitle the Option Grantee to acquire one fully
paid-up equity share of the Company having a face value of ₹2/-
each.
2 Whether the Scheme is in Yes. ESOP 2026 is in compliance with the SEBI (Share Based
terms of the SEBI (Share Employee Benefits and Sweat Equity) Regulations, 2021 (“SEBI
Based Employee Benefits SBEB Regulations”).
and Sweat Equity)
Regulations, 2021
3 Total number of shares 38,236 equity shares of face value of ₹2/- each may arise upon
covered by these Options exercise of the Options, assuming vesting and exercise of all
Options granted. Each Option is convertible into one equity
share of the Company.
4 Pricing formula / Exercise The Options have been granted at an Exercise Price of ₹513.60
Price (Rupees Five Hundred Thirteen and Sixty Paise only) per Option,
as determined by the NRC in accordance with ESOP 2026 and
specified in the respective Grant Letters.
5 Options vested Not applicable at this stage. The Options granted are subject to
a minimum vesting period of one year from the Grant Date and
fulfilment of the applicable Vesting Conditions and other terms
specified in the respective Grant Letters.
6 Time within which The Vested Options may be exercised within a maximum period
Options may be exercised of 5 (five) years from the date of each respective Vesting, or
within such shorter period as may be prescribed by the NRC and
specified in the relevant Grant Letter, subject to the terms and
conditions of ESOP 2026. In the event of cessation of
employment/service or other specified events, the Exercise
Period shall be governed by the applicable provisions of ESOP
2026.
7 Options exercised Not applicable at this stage.
8 Money realised by Not applicable at this stage.
exercise of Options
9 Total number of shares Not applicable at this stage.
arising as a result of
exercise of Options
10 Options lapsed Not applicable at this stage.
11 Variation of terms of Not applicable at this stage.
Options
12 Brief details of significant The Options shall be governed by ESOP 2026, the respective
terms Grant Letters and the SEBI SBEB Regulations, and shall vest
subject to the fulfilment of the applicable vesting conditions as
approved by the NRC and set out in the respective Grant Letters,
as accepted by the Option Grantees. The Options shall, in all
circumstances, be subject to the applicable minimum vesting
period prescribed under ESOP 2026 and applicable law.
13 Subsequent changes or Not applicable at this stage.
cancellation or exercise
of such Options
14 Diluted earnings per Not applicable at this stage.
share pursuant to issue of
equity shares on exercise
of Options